Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased eIF-2 alpha expression in mitogen-activated primary T lymphocytes.

R B Cohen1, T R Boal, B Safer

  • 1Laboratory of Molecular Hematology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

The EMBO Journal
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors.

Cancer chemotherapy and pharmacology·2014
Same author

Prospective clinical trial to compare vincristine and vinblastine in a COP-based protocol for lymphoma in cats.

Journal of veterinary internal medicine·2012
Same journal

Scalable phosphotyrosine enrichment with SH2 superbinder enables deep profiling of EGF responses.

The EMBO journal·2026
Same journal

Essential nucleus-apical pole linkage maintains division fidelity during Plasmodium progeny formation.

The EMBO journal·2026
Same journal

From cell atlases to mechanisms: bridging scRNA-seq discovery with in vivo genetics.

The EMBO journal·2026
Same journal

Mitochondrial calcium regulates lipid metabolism by modulating tethering of mitochondria to lipid droplets.

The EMBO journal·2026
Same journal

Chromosome condensation mechanically primes the nucleus for mitosis.

The EMBO journal·2026
Same journal

NDR kinase SAX-1 controls dendrite branch-specific elimination during neuronal remodeling in C. elegans.

The EMBO journal·2026
See all related articles

Resting T cells have low protein synthesis and eIF-2 alpha mRNA. PHA stimulation increases eIF-2 alpha mRNA by stabilizing the primary transcript, indicating a key role in T cell activation.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • Human T cells in the G0 phase exhibit low protein synthesis rates.
  • Eukaryotic initiation factor 2 alpha (eIF-2 alpha) is crucial for regulating translation initiation.

Purpose of the Study:

  • To investigate the regulation of eIF-2 alpha gene expression in normal human T cells upon phytohemagglutinin (PHA) stimulation.
  • To understand the mechanisms controlling eIF-2 alpha mRNA levels during T cell activation.

Main Methods:

  • Nuclear run-on assays to assess gene transcription rates.
  • Actinomycin D chase experiments to determine mRNA half-life.
  • Analysis of nuclear RNA using intron-specific probes to evaluate primary transcript stability.

Related Experiment Videos

Main Results:

  • Low eIF-2 alpha gene transcription rates were observed in G0 T cells, increasing twofold with PHA treatment.
  • The half-life of eIF-2 alpha mRNA remained consistent between G0 and PHA-treated T cells.
  • Increased eIF-2 alpha expression post-PHA stimulation is primarily attributed to intranuclear stabilization of the primary transcript.
  • This upregulation does not necessitate new protein synthesis.

Conclusions:

  • eIF-2 alpha gene expression is part of the primary response program in T cells activated by mitogens.
  • Intranuclear stabilization of the primary transcript is a key regulatory mechanism for eIF-2 alpha expression in activated T cells.